Head-to-head · WeighScore
ARSYNL Rx vs Tablet Health
The verdict
ARSYNL Rx takes it — 59.1/100 to 47.6/100.
ARSYNL Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. ARSYNL Rx is a veteran-founded multi-service telehealth platform offering compounded GLP-1 weight-loss treatment — compounded semaglutide and tirzepatide, including a needle-free tirzepatide hypospray —…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | ARSYNL Rx | Tablet Health |
|---|---|---|
| WeighScore | 59.1/100 | 47.6/100 |
| Grade | C | C |
| Scorecard rank | #348 | #495 |
| Semaglutide | $233/mo (compounded) | Not disclosed |
| Tirzepatide | $366/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #348 · C
Strengths
- Offers compounded semaglutide and tirzepatide, including a needle-free tirzepatide hypospray option
- Veteran-founded telehealth with clinician-prescribed, personalized treatment
- Multi-service platform — also covers hair restoration, TRT, sexual health, and longevity
- Medications shipped discreetly to your home
Where it loses points
- Pricing is not shown until you select a product (product pages sit behind a bot-verification gate)
- Compounded GLP-1s are not FDA-approved finished products
- Compounding pharmacy partner and exact state coverage are not disclosed on the site
- No LegitScript certification visible on the accessible pages
Graded #495 · C
Strengths
- LegitScript Certified
- Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
- Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
- Mid-tier pricing starting $179–$299/mo across all four product variants
- No commitment — cancel anytime
Where it loses points
- States served not published — you must complete the intake quiz to learn eligibility
- No founder, CEO, medical director, or pharmacist-in-charge named anywhere
- No BBB profile found
- Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.